Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer (Hypo-FLAME)

NCT02853110 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT02853110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer (Hypo-FLAME)
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
November 1, 2018
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer adenocarcinoma